搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
15 天
Kymera Therapeutics四季度业绩不及预期,股价下跌
马萨诸塞州沃特敦 - 开发蛋白质降解药物的临床阶段生物制药公司Kymera Therapeutics, Inc. (NASDAQ: KYMR )公布的2024年第四季度财务业绩未能达到分析师预期。消息公布后,公司股价下跌1.5%。
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Sworn in as Canada's PM
Legendary sportswriter dies
Strikes deal with DOGE
Man hit by motorcade, dies
March megastorm
US influencer sparks outrage
Top intelligence agency visit
To host Golden Globes
Smishing scam warning
Plane engine catches fire
To cut 2,000+ jobs
Trump Tower protest
Influential WY senator dies
Khalil sues Columbia
Hamas to release hostage
‘Ted Lasso’ is coming back
Teixeira pleads guilty
Won't block GOP bill
Ordered to reinstate workers
Top FDA lawyer resigns
FDA, NIH nominees advance
Senate confirmation hearing
Exits bankruptcy protection
UN report accuses Israel
Ditch new stadium deal
$3B deal to extend rights
Swatting call about gunman
IRS demotes chief counsel
Texas Tech closes campus
CDC nomination withdrawn
Out as creative director
Says he supports ceasefire
反馈